Influenza A(H3N2) Subclade K (J.2.4.1): Molecular Characterization, Antigenic Divergence, and Global Spread During the 2025/26 Season. [PDF]
Branda F +5 more
europepmc +1 more source
Vaccine Effectiveness Estimates Against Influenza A(H3N2)-Associated Hospitalized Severe Acute Respiratory Infections in Beijing, China, 2025/26 Influenza Season. [PDF]
Ma C +13 more
europepmc +1 more source
Antiviral Resistance in Influenza: Clinical and Public Health Implications. [PDF]
Ngiam JN, Koh MCY, Hayden FG.
europepmc +1 more source
Gene Expression Profiles of Inflammatory Mediators in Influenza A and B Virus Infections: Insights from Riyadh, Saudi Arabia (2020-2023). [PDF]
Alkubaisi NA +4 more
europepmc +1 more source
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence. [PDF]
Harvey R +29 more
europepmc +1 more source
Reduction of virus isolation effectiveness from throat swab double positive to H1N1pdm09 and H3N2 influenza A virus strain with SARS-CoV-2 virus in cell cultures. [PDF]
Arvia R, Tassone V, Giannecchini S.
europepmc +1 more source
Methods for detecting highly pathogenic avian influenza H5N1 virus in dairy processing environments. [PDF]
Puchades-Colera P +3 more
europepmc +1 more source
Intramuscular administration of influenza hemagglutinin in one hind leg elicits similar protective immune responses as administration in two hind legs. [PDF]
Uno N, Ross TM.
europepmc +1 more source
Influenza A virus infection impairs neuronal activity in human iPSC-derived NGN2 neural co-cultures. [PDF]
Benavides FFW +9 more
europepmc +1 more source
Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults. [PDF]
van Pul L +8 more
europepmc +1 more source

